According to the literature, NR2F2 was overexpressed in ovarian cancer and prostate cancer, and its dysregulation was associated with testis developmental defects63,64, uterine fibroids65, and uterine implantation failure66. The gene discussed is NR2F2; the disease is Familial prostate cancer.